Philips Joins New Venture Capital Fund to Foster Innovation in Healthcare

Royal Philips ElectronicsRoyal Philips Electronics (NYSE: PHG, AEX: PHI) today announced that it has joined Gilde Healthcare III - a new venture capital fund focusing on innovative early and growth stage healthcare technology companies in Europe and the USA that are active in developing and commercializing new patient-centric healthcare solutions, medical technologies and therapeutics.

As a global leader in Health and Well-being, Philips is investing in Gilde Healthcare III in order to foster innovation in areas of strategic interest to its Healthcare business. Philips' anchor investment in Gilde Healthcare III is in line with its policy of open innovation and its belief that the most effective way to deploy venture capital is via an independent fund that can leverage the expertise of a professional fund manager and the other investors in the fund. Gilde Healthcare III will be fully independent of, and complementary to Philips' existing innovation efforts, including the Philips Healthcare Incubator.

"Over the past years the venturing community has been instrumental in bringing breakthrough healthcare innovations to the market," said Steve Rusckowski, CEO of Philips Healthcare. "Through our participation in the Gilde Healthcare III venture capital fund, we are taking another step forward in driving innovation in areas of strategic interest to Philips in healthcare. At the same time we will become even more connected to the venturing community, which is an important element of Philips' open innovation approach."

As one of the fund's anchor investors, Philips has contributed to shaping part of the fund's innovative scope. Patient-centric healthcare is an emerging approach to healthcare delivery that focuses on the patient experience as well as on improved clinical outcomes. Within this value space, the Gilde Healthcare III fund will focus on home healthcare solutions, sleep improvement techniques, image-guided interventions/therapies and clinical decision support, with particular emphasis on cardiology, oncology and women's health.

Philips holds a minority share in the fund and it is being joined by additional institutional financial investors. The Gilde Healthcare III fund has a target size of EUR 200 million (USD 250 million). It will be managed by Gilde Healthcare Partners - a Dutch venture and growth capital firm that currently has more than EUR 300 million under management.

Related news articles:

About Royal Philips Electronics
Royal Philips Electronics of the Netherlands (NYSE: PHG, AEX: PHI) is a diversified Health and Well-being company, focused on improving people's lives through timely innovations. As a world leader in healthcare, lifestyle and lighting, Philips integrates technologies and design into people-centric solutions, based on fundamental customer insights and the brand promise of "sense and simplicity". Headquartered in the Netherlands, Philips employs more than 116,000 employees in more than 60 countries worldwide. With sales of EUR 23 billion in 2009, the company is a market leader in cardiac care, acute care and home healthcare, energy efficient lighting solutions and new lighting applications, as well as lifestyle products for personal well-being and pleasure with strong leadership positions in flat TV, male shaving and grooming, portable entertainment and oral healthcare. News from Philips is located at www.philips.com/newscenter.

Most Popular Now

ChatGPT 4o Therapeutic Chatbot 'Ama…

One of the first randomized controlled trials assessing the effectiveness of a large language model (LLM) chatbot 'Amanda' for relationship support shows that a single session of chatbot therapy...

AI Tools Help Predict Severe Asthma Risk…

Mayo Clinic researchers have developed artificial intelligence (AI) tools that help identify which children with asthma face the highest risk of serious asthma exacerbation and acute respiratory infections. The study...

AI Distinguishes Glioblastoma from Look-…

A Harvard Medical School–led research team has developed an AI tool that can reliably tell apart two look-alike cancers found in the brain but with different origins, behaviors, and treatments. The...

AI Model Forecasts Disease Risk Decades …

Imagine a future where your medical history could help predict what health conditions you might face in the next two decades. Researchers have developed a generative AI model that uses...

Overcoming the AI Applicability Crisis a…

Opinion Article by Harry Lykostratis, Chief Executive, Open Medical. The government’s 10 Year Health Plan makes a lot of the potential of AI-software to support clinical decision making, improve productivity, and...

Smart Device Uses AI and Bioelectronics …

As a wound heals, it goes through several stages: clotting to stop bleeding, immune system response, scabbing, and scarring. A wearable device called "a-Heal," designed by engineers at the University...

Dartford and Gravesham Implements Clinis…

Dartford and Gravesham NHS Trust has taken a significant step towards a more digital future by rolling out electronic test ordering using Clinisys ICE. The trust deployed the order communications...